Carlton Hofferkamp & Jenks Wealth Management, LLC Amgen Inc Transaction History

Carlton Hofferkamp & Jenks Wealth Management, LLC

$307 Million
Q3 2024

A detailed history of Carlton Hofferkamp & Jenks Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Carlton Hofferkamp & Jenks Wealth Management, LLC holds 4,789 shares of AMGN stock, worth $1.27 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

4,789

Previous 4,860 1.46%

Holding current value

$1.27 Million

Previous $1.52 Million 1.65%

% of portfolio

0.5%

Previous 0.62%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$309.38 - $337.38 $21,965 - $23,953	-71 Reduced 1.46%	4,789 $1.54 Million
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $7,882 - $9,579	-30 Reduced 0.61%	4,860 $1.52 Million
Q1 2024 Apr 26, 2024	BUY	$268.87 - $324.56 $12,099 - $14,605	45 Added 0.93%	4,890 $1.39 Million
Q4 2023 Jan 25, 2024	SELL	$255.7 - $288.46 $27,871 - $31,442	-109 Reduced 2.2%	4,845 $1.4 Million
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $91,833 - $114,013	-420 Reduced 7.82%	4,954 $1.33 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $11,142 - $13,175	-52 Reduced 0.96%	5,374 $1.19 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $14,450 - $17,612	-64 Reduced 1.17%	5,426 $1.31 Million
Q4 2022 Jan 30, 2023	SELL	$229.03 - $291.01 $22,444 - $28,518	-98 Reduced 1.75%	5,490 $1.44 Million
Q3 2022 Oct 24, 2022	SELL	$224.46 - $253.15 $19,976 - $22,530	-89 Reduced 1.57%	5,588 $1.41 Million
Q2 2022 Jul 12, 2022	BUY	$230.71 - $256.74 $1,153 - $1,283	5 Added 0.09%	5,677 $1.41 Million
Q1 2022 Apr 11, 2022	BUY	$219.27 - $242.57 $10,963 - $12,128	50 Added 0.89%	5,672 $1.43 Million
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $44,748 - $51,210	225 Added 4.17%	5,622 $1.27 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $158,353 - $185,530	746 Added 16.04%	5,397 $1.14 Million
Q2 2021 Jul 19, 2021	BUY	$233.58 - $259.14 $49,285 - $54,678	211 Added 4.75%	4,651 $1.15 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $6,657 - $7,758	30 Added 0.68%	4,440 $1.13 Million
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $1,081 - $1,288	-5 Reduced 0.11%	4,410 $1.1 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $22,291 - $24,790	95 Added 2.2%	4,415 $1.06 Million
Q2 2020 Jul 30, 2020	SELL	$197.81 - $242.74 $60,332 - $74,035	-305 Reduced 6.59%	4,320 $1.08 Million
Q1 2020 Apr 30, 2020	BUY	$182.24 - $241.7 $9,112 - $12,085	50 Added 1.09%	4,625 $1.09 Million
Q4 2019 Jan 28, 2020	SELL	$189.21 - $243.2 $22,515 - $28,940	-119 Reduced 2.54%	4,575 $1.02 Million
Q3 2019 Oct 11, 2019	BUY	$174.11 - $208.62 $8,705 - $10,431	50 Added 1.08%	4,694 $933,000
Q2 2019 Jul 18, 2019	BUY	$166.7 - $195.41 $55,344 - $64,876	332 Added 7.7%	4,644 $822,000
Q1 2019 Apr 22, 2019	BUY	$180.87 - $203.88 $18,267 - $20,591	101 Added 2.4%	4,312 $819,000
Q4 2017 Jan 26, 2018	SELL	$168.79 - $188.59 $6,751 - $7,543	-40 Reduced 0.94%	4,211 $732,000
Q3 2017 Oct 06, 2017	BUY	$167.29 - $191.0 $711,149 - $811,941	4,251	4,251 $792,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlton Hofferkamp & Jenks Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carlton Hofferkamp & Jenks Wealth Management, LLC with notifications on news.

Account

Carlton Hofferkamp & Jenks Wealth Management, LLC Amgen Inc Transaction History